LabCompass

Yujin Park

Medicine · Indiana University

Publications

32

Citations

266

Est. group size

Recurring co-author estimate

Active years

10

Publishing since 2016

Research summary
AI-generated

Yujin Park conducts biomedical research spanning several areas, with a notable focus on finding and testing drugs against Mycobacterium abscessus, a difficult-to-treat bacterial infection. Other work includes tuberculosis detection in kidney-disease patients, environmental toxicology using zebrafish to study how chemicals disrupt hormones, and digital health tools for managing diabetes.

Antibacterial drug discovery (Mycobacterium abscessus)Tuberculosis detection and epidemiologyEnvironmental toxicology and endocrine disruption (zebrafish)Digital health and diabetes managementDrug delivery and biomaterials

Publication activity grew through the early 2020s, peaking around 2022, and has remained fairly steady at roughly 3-5 papers per year since.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.6/year recently
17182019: 1 publication192020: 2 publications202021: 4 publications212022: 9 publications9222023: 6 publications232024: 3 publications242025: 5 publications2526
Recent publications
Publishes in
  • Frontiers in Immunology×3
  • Research Square×3
  • Transplantation×3
  • ASAIO Journal×2
  • American Journal Of Pathology×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile